Study randomization was stratified by age group and in the prespecified analysis of participants aged 45 n16 at the time of treatment the treatment group demonstrated a statistically significant 43point improvement on NSAA total score at 48 weeks post treatment compared to a 19point improvement in the agematched placebo group P00172